On Monday (June 25) various hopefuls and established names of the Canadian cannabis industry gathered for the International Cannabis Business Conference (ICBC) held in Vancouver.
Hosted by ICBC, the Vancouver iteration of this event offered a variety of panels of interest for investors of the cannabis space. The Investing News Network (INN) was there at the show attending numerous panel discussions and gaining further insight into the future of the Canadian cannabis space.
“Canada has helped bring cannabis into the mainstream more than any country, first by implementing sensible medical laws, and now by passing the Cannabis Act and ending prohibition for all adults,” Alex Rogers executive producer of the ICBC said in an emailed statement prior to the show.
If you missed the show, don’t worry – below is an overview of the show’s key highlights.
Consulting firm warns cannabis investors on potential bubble
Nic Easley, CEO of 3C Consulting, a strategic advisor for cannabis ventures, warned investors in his panel to be aware of an incoming bubble which will be worse, according to him, than the infamous dotcom bubble of the late ‘90s.
“To call the Canadian public cannabis market a bubble is a third of an understatement, because it’s three times worse than the dotcom bubble,” Easley said.
Despite the gloomy prediction, the consulting firm executive told the room that in his estimation, Canada– in the next two to three years–will be what he called the ‘glory days’ for the public markets.
Like other experts Easley indicated there will come a point where the product produced by Canadian LP’s will be plenty to service the entire Canadian market. These companies will need to diversify quickly in order to stay relevant in the eyes of investors, Easley said.
“If you buy 50 Canadian public companies right now, you are making a huge mistake as an investor,” Easley warned investors as he described the potential impact of a bubble crashing in Canada.
M&A activity strategies
During a panel focused on the recent trend of mergers and acquisition activity in the cannabis space Anthony Holler CEO of Sunniva (CSE:SNN) told the audience his company doesn’t have the same option as some of the larger public players to simply acquire assets and figure out how they integrate into their overall strategy later.
“We can’t do that, that’s impossible for us to do so we have to try and understand the work, understand where the market is going and say ‘we don’t have that skill set,’” Holler said.
Holler added he’s seen through these acquisitions people involved with them don’t end up as part of the transactions. Instead, he said, his strategy is to bring in the people at the center of his acquisition.
“We don’t buy people and then say ‘why don’t you get lost, we don’t need you,’” Holler said of M&A strategy.
Cannabis’ growing presence in public markets
The second panel of the day was hosted by the director of listings development for the Canadian Securities Exchange (CSE), Anna Serin. The CSE seen a rush of cannabis listings thanks to its disclosure-based approach when it comes to US focused companies seeking to raise capital in Canada.
During the panel Serin said the CSE has 71 current cannabis issuers which represent a C$5.5 billion market cap. She told the audience over the past 12 months, CSE-listed companies have raised nearly C$2 billion with 58 percent of it in the cannabis sector.
“One of the biggest concerns from people listing with us was our liquidity, the cannabis sector has shot us through the roof and put us on the map,” Serin said.
Yasmin Gordon, a senior investment advisor for Canaccord Genuity told the room she has noticed a trend of less risk when it comes to financing options for cannabis companies. The entry of Canadian banks into the financing sector for cannabis companies adds to the de-risking trend.
The group of speakers for the CSE-led panel was asked about the high valuations cannabis companies are seeing when a lot of questions remain on the actual size of their revenues and potential legitimate growth.
Arthur Kwan, managing partner with Athena Capital Advisors and CEO of CannaIncome Fund Corporation, said he sees these companies still in the emerging phase with a bulk of their revenues arriving later–but still coming.
Kwan explained when looking at metrics such as revenue and earnings before interest, tax, depreciation and amortization (EBITDA) compared to previous years, prices for these companies start to become “a bit more reasonable… still expensive, but justifiable.”
For more stories coming out of the ICBC show floor be sure to follow @INN_Cannabis for all the latest in the cannabis public market.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).